- Successfully defended Neurotrope Biotechnology Inc in a securities class action case, achieving a complete victory at the motion to dismiss stage.
- Served as lead trial counsel in arbitration proceedings, obtaining full dismissal of all charges against professional sports team in a matter alleging variety of contract and tort claims.
- Obtained full dismissal on motion to dismiss in real estate matter pending in New York Supreme Court.
- Represented Italian client, successfully obtaining determination by International Trade Commission, later affirmed by the Federal Circuit, barring importation of infringing products.
Mintz secured dismissal of a securities fraud case against biopharmaceutical company Neurotrope. Mintz argued that securities laws do not require disclosure of the statistical methodology behind announced clinical trial results.